CVS Group (CVSG)

Sector:

Retailers

Index:

FTSE AIM 50

993.00p
   
  • Change Today:
    -23.00p
  • 52 Week High: 1,196.00p
  • 52 Week Low: 798.00p
  • Currency: UK Pounds
  • Shares Issued: 71.74m
  • Volume: 231,991
  • Market Cap: £712.38m
  • RiskGrade: 136

CVS Group reports solid year for revenue, earnings growth

By Josh White

Date: Thursday 23 Sep 2021

LONDON (ShareCast) - (Sharecast News) - CVS Group reported a 19.2% improvement in revenue in its final results on Thursday, to £510.1m, with "strong" group like-for-like growth of 17.4% benefitting from "favourable" market dynamics, and its focus on providing quality care to clients and animals.
The AIM-traded veterinary services provider said it delivered adjusted EBITDA growth of 37.3% to £97.5m for the year ended 30 June, which it put down to the increase in revenue across all divisions, and "effective" cost management.

Profit before income tax increased 234.3% to £33.1m, while leverage fell to 0.68x from 1.14x, as a result of strong EBITDA growth and a reduction in net debt.

Cash generated from operations decreased to £80.3m from £94.8m, despite the increase in adjusted EBITDA, due to VAT and taxes deferred in the prior year amid the Covid-19 pandemic, paid in the current year.

Looking ahead, CVS reported total sales growth of 17.5% in the first two months of the new financial year, with like-for-like sales up 14.4% thanks to a further price increase in July, in addition to the delayed price increase implemented in January.

It reported a "strong" adjusted EBITDA margin of 19.5% for the first two months, up from 18.7% a year earlier, while its vet vacancy rate was "stable", averaging 8.8% for the last 12 months to the end of August, compared to 6.8% a year ago, with "continued initiatives" in place to attract and retain talent.

Those initiatives included an acceleration in annual pay increases from 1 July to align with the start of the financial year, while remuneration was changed in line with feedback focusing on fixed income for clinicians, and introducing bonus schemes to reward collaboration across the group, with an additional day's holiday awarded for each year worked at CVS, up to a maximum of five years.

Continued growth was reported in the company's 'Healthy Pet Club' scheme to 455,000 members as at 31 August, up 7.9% year-on-year.

CVS noted that it had made one new acquisition since the financial year ended, adding that its leverage was "flat" at 0.7x, compared to 0.8x at the end of August 2020.

"We have delivered a very strong performance for the year with credit to every single one of our colleagues for their extraordinary efforts to provide the best possible service to our customers and their animals, against a difficult backdrop of restrictions and evolving regulatory guidance," said chief executive officer Richard Fairman.

"These results demonstrate the resilience of our fully integrated veterinary model and our commitment to providing the very highest standards of clinical care.

"We continue to expand and develop our business, and, alongside our ongoing investments in high quality facilities and practices, we have welcomed a number of new vets and nurses to the group, as demand for veterinary services continues to increase in light of rising pet ownership."

Fairman said the company was looking into a number of opportunities to grow the business through favourable consumer trends, further improving its specialist offering, and by continuing to invest in support.

"Although management expectations for the full-year are not based on attaining annual growth at the high levels of the first two months, the very positive start to the new financial year is encouraging.

"We remain focused on providing first class veterinary care and look forward with confidence."

At 0854 BST, shares in CVS Group were up 2.81% at 2,565p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CVS Group Market Data

Currency UK Pounds
Share Price 993.00p
Change Today -23.00p
% Change -2.26 %
52 Week High 1,196.00p
52 Week Low 798.00p
Volume 231,991
Shares Issued 71.74m
Market Cap £712.38m
RiskGrade 136

CVS Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.78% below the market average46.78% below the market average46.78% below the market average46.78% below the market average46.78% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
7.01% below the market average7.01% below the market average7.01% below the market average7.01% below the market average7.01% below the market average
5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average
Income
90.81% below the market average90.81% below the market average90.81% below the market average90.81% below the market average90.81% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average
Growth
35.27% below the market average35.27% below the market average35.27% below the market average35.27% below the market average35.27% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CVS Group Dividends

  Latest Previous
  Final Final
Ex-Div 31-Oct-24 02-Nov-23
Paid 29-Nov-24 08-Dec-23
Amount 8.00p 7.50p

Trades for 03-Apr-2025

Time Volume / Share Price
16:35 297 @ 993.00p
16:35 297 @ 993.00p
16:35 174 @ 993.00p
16:35 31,271 @ 993.00p
16:35 141 @ 993.00p

CVS Group Key Personnel

CEO Richard Fairman
Finance Director Robin Alfonso

Top of Page